New 6-Month pill combo could beat Drug-Resistant TB
Disease control
Ongoing
This study tests a 6-month, all-oral drug combination (BDLLfxC) for people with rifampin-resistant tuberculosis (TB). About 120 Chinese teens and adults will take the pills and be followed for up to 72 weeks. The goal is to see if the regimen can cure the infection safely, with f…
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated May 04, 2026 16:24 UTC